share_log

Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management Fund III L.P.(15.1%),Pontifax Management III G.P. (2011) Ltd.(15.1%), etc.

Enlivex Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Pontifax Management Fund III L.P.(15.1%),Pontifax Management III G.P. (2011) Ltd.(15.1%)等

美股SEC公告 ·  2019/02/14 10:20
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息